TERNS PHARMACEUTICALS INC (TERN) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:TERN • US8808811074

34.2 USD
-0.06 (-0.18%)
At close: Jan 29, 2026
34.5 USD
+0.3 (+0.88%)
After Hours: 1/29/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
TERN revenue by date.TERN revenue by date.
1M
-100.00%
3.281M61.376M
1,770.65%
275.69M
349.18%
346.07M
25.53%
799.71M
131.08%
1.242B
55.31%
EBITDA
YoY % growth
TERN ebitda by date.TERN ebitda by date.
-70M
-280.64%
-36.64M
47.66%
-49.35M
-34.69%
-64.25M
-24.72%
-104.478M
-66.15%
-105.06M
0.70%
-112.742M
-11.02%
-135.836M
-20.48%
-167.76M
-23.50%
-182.07M
-8.53%
-162.792M
10.59%
46.104M
128.32%
204.82M
344.26%
897.5M
338.19%
1.793B
99.78%
EBIT
YoY % growth
TERN ebit by date.TERN ebit by date.
-70.2M
-280.28%
-37.03M
47.25%
-49.86M
-34.65%
-64.802M
-24.41%
-135.246M
-65.34%
-105.442M
0.67%
-114.691M
-12.58%
-136.601M
-19.10%
-160.415M
-17.43%
-174.357M
-8.69%
-242.686M
-39.19%
-81.765M
66.31%
132.77M
262.38%
523.59M
294.36%
912.44M
74.27%
Operating Margin
TERN operating margin by date.TERN operating margin by date.
N/AN/A-4,986.00%N/AN/AN/AN/AN/AN/A-5,314.16%-395.41%-29.66%38.37%65.47%73.47%
EPS
YoY % growth
TERN eps by date.TERN eps by date.
N/AN/A-2.34
28.53%
-1.92
21.79%
-1.36
30.60%
-1.23
11.02%
-1.11
2.11%
-1.30
-17.25%
-1.50
-15.31%
-1.63
-9.12%
-1.39
15.00%
-0.72
47.79%
0.25
134.27%
3.02
1,117.96%
5.30
75.25%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.30
-23.72%
-0.30
-13.82%
-0.31
-18.87%
-0.34
-25.94%
-0.37
-23.78%
-0.35
-17.19%
-0.36
-15.51%
-0.35
-1.99%
-0.35
5.64%
-0.34
2.94%
-0.34
5.71%
-0.34
2.94%
Revenue
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth
-30.206M
-17.86%
-32.354M
-18.20%
-32.509M
-19.01%
-32.708M
-18.35%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-30.921M
-19.16%
-33.15M
-20.87%
-34.2M
-24.90%
-35.369M
-27.61%
-41.269M
-33.47%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.27
3.57%
-0.300.0310.70%
Q2 2025
Q2Q % growth
-0.26
16.13%
-0.300.0412.10%
Q1 2025
Q2Q % growth
-0.26
13.33%
-0.290.038.96%
Q4 2024
Q2Q % growth
-0.24
17.24%
-0.320.0824.07%
Q3 2024
Q2Q % growth
-0.28
33.33%
-0.330.0514.33%
Q2 2024
Q2Q % growth
-0.31
-24.00%
-0.350.0410.61%
Q1 2024
Q2Q % growth
-0.30
3.23%
-0.340.0412.85%
Q4 2023
Q2Q % growth
-0.29 -0.300.012.71%
Q3 2023
Q2Q % growth
-0.42
4.55%
-0.31-0.11-34.76%
Q2 2023
Q2Q % growth
-0.25
54.55%
-0.350.1027.68%
Q1 2023
Q2Q % growth
-0.31
43.64%
-0.27-0.04-13.53%
Q4 2022
Q2Q % growth
-0.29
48.21%
-0.440.1533.88%
Q3 2022
Q2Q % growth
-0.44
6.38%
-0.530.0917.04%
Q2 2022
Q2Q % growth
-0.55
-27.91%
-0.610.069.12%
Q1 2022
Q2Q % growth
-0.55
37.50%
-0.660.1116.18%
Q4 2021
Q2Q % growth
-0.56
98.19%
-0.640.0812.39%
Q3 2021
Q2Q % growth
-0.47 -0.620.1523.63%
Q2 2021
Q2Q % growth
-0.43 -0.720.2940.62%
Q1 2021
Q2Q % growth
-0.88 -0.79-0.09-11.56%
Q4 2020
Q2Q % growth
-30.94 -0.93-30.01-3,233.33%
TERN Yearly EPS VS EstimatesTERN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth

-100.00%
%
TERN Yearly Revenue VS EstimatesTERN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.34% 4.96% 0.08% 2.31%
RevenueN/A N/A N/A N/A